CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 4 Open-market buy Director bought 5,000 shares at $2.00 ($10,000)
- 4 Open-market buy CEO and Interim CFO bought 10,000 shares at an average $2.02 ($20,180)
- 4 Open-market buy Director bought 15,000 shares at an average $1.99 ($29,900)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,500 shares at $2.01 ($5,025)
- 4 Open-market buy Director bought 3,000 shares at $2.02 ($6,060)
- 10-K Report Annual Report
- 8-K Event Material agreement · Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 8-K Event Bylaws or fiscal year change · Other events
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Returned to the company President, CEO and Interim CFO returned 120,501 shares (to the company)
Page 17 of 26 · 511 filings